Has Sametta Sanyaolu received payments from drug or device companies?

Yes. Drug and device makers reported $37,370 in general payments to Sametta Sanyaolu across 2,060 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sametta Sanyaolu did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sametta Sanyaolu come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sametta Sanyaolu

Family · Fulton, MDNPI 1730695503

Payments from drug & device makers

$37,370in general payments, 2019–2025

Across 2,060 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$8K
Biogen$3K
Teva Pharmaceuticals USA, Inc.$3K
Pfizer$2K
Amgen$1K
ANI Pharmaceuticals, Inc.$1K
plus $19K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	635	$7,695
Biogen	154	$3,118
Teva Pharmaceuticals USA, Inc.	70	$2,599
Pfizer	100	$1,769
Amgen(2 entities)	62	$1,395
ANI Pharmaceuticals, Inc.	66	$1,314
Lundbeck LLC	71	$1,265
UCB, Inc.	60	$1,194
Amneal Pharmaceuticals LLC	34	$1,029
Argenx US, Inc.	44	$1,006
Neurocrine Biosciences, Inc.	30	$954
Bristol Myers Squibb	47	$907
Biohaven Pharmaceutical Holding Company Ltd.	53	$870
Neurelis, Inc.	39	$845
Eisai Inc.	36	$771
Johnson & Johnson	67	$761
Lilly USA, LLC	28	$690
Axsome Therapeutics, Inc.	30	$662
Kyowa Kirin, Inc.	31	$650
Genentech USA, Inc.	23	$574
Currax Pharmaceuticals LLC	56	$521
CSL Behring	19	$507
Vanda Pharmaceuticals Inc.	19	$496
Sunovion Pharmaceuticals Inc.	29	$462
AstraZeneca	16	$427
TG Therapeutics, Inc.	21	$421
Scilex Pharmaceuticals Inc.	17	$361
Sumitomo Pharma America, Inc.	22	$343
Catalyst Pharmaceuticals, Inc.	16	$294
MDD US Operations, LLC	3	$293
Mallinckrodt Hospital Products Inc.	15	$283
Collegium Pharmaceutical, Inc.	15	$231
Alnylam Pharmaceuticals Inc.	9	$228
Biohaven Pharmaceuticals, Inc.	14	$208
Takeda Pharmaceuticals U.S.A., Inc.	8	$197
Avion Pharmaceuticals	14	$170
Avanir Pharmaceuticals, Inc.	9	$164
Grifols USA, LLC	8	$164
Acorda Therapeutics, Inc	8	$161
Impel Pharmaceuticals Inc.	7	$143
Sanofi	5	$124
Azurity Pharmaceuticals, Inc.	5	$112
Supernus Pharmaceuticals, Inc.	4	$96
Otsuka America Pharmaceutical, Inc.	4	$86
Upsher-smith Laboratories LLC	4	$70
Livanova USA, Inc.	3	$68
Springworks Therapeutics, Inc.	3	$68
Sandoz	2	$54
Banner Life Sciences, LLC	3	$54
Jazz Pharmaceuticals Inc.	2	$51
Impel Pharmaceuticals LLC	2	$45
Almatica Pharma LLC	2	$44
Tanabe Pharma America, Inc.	2	$43
Adamas Pharmaceuticals, Inc.	2	$40
Novocure Inc.	1	$38
Merck	2	$36
Insightec,inc	1	$32
SK Life Science, Inc.	1	$30
Abbott	1	$26
Octapharma USA, Inc.	1	$26

How this compares

$37,370 in reported general payments places this provider in the 95th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland →

Medicare billing

Part B allowed, 2024

$66,406

Medicare patients

259

Services billed

1,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Fulton

Ariana ChaoLutherville$727K
Erika HoffmanPotomac$226K
Caroline MansySalisbury$106K
Hazel Jones-ParkerBaltimore$96K
Brittany WilsonBaltimore$88K
Meredith SagalHunt Valley$82K
Sharon Dudley-BrownBel Air$67K
Joy MaulikSalisbury$47K
Kristin AttiogbeChevy Chase$42K
Lisa ScottiBaltimore$35K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →